Bayer’s Roundup Settlements Soar as Glyphosate Controversy Rages On
Los Angeles, CA – Bayer, the pharmaceutical company that acquired Roundup brands as part of its purchase of Monsanto, has announced a $2 billion settlement to cover future claims related to the controversial weedkiller. The settlement comes after years of legal battles over the chemical glyphosate, the active ingredient in Roundup. Glyphosate has been at the center of controversy due to differing opinions on its safety. In 2015, the World Health Organization’s cancer research agency concluded that glyphosate was probably carcinogenic to humans. However, many regulatory agencies, including the U.S. EPA, classify the chemical as … Read more